Cargando…

Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study

BACKGROUND: Sarcopenia is an age-related and skeletal muscle disorder involving the loss of muscle mass or strength, and physiological function. Although the diagnostic indicators used in the different guidelines are for muscle mass, strength and physical performance, there are currently no uniform...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Mengting, Zhang, He, Liu, Qianhui, Ding, Fei, Deng, Yiping, Hou, Lisha, Wang, Hui, Yue, Jirong, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702640/
https://www.ncbi.nlm.nih.gov/pubmed/34956096
http://dx.doi.org/10.3389/fendo.2021.785045
_version_ 1784621282898214912
author Yin, Mengting
Zhang, He
Liu, Qianhui
Ding, Fei
Deng, Yiping
Hou, Lisha
Wang, Hui
Yue, Jirong
He, Yong
author_facet Yin, Mengting
Zhang, He
Liu, Qianhui
Ding, Fei
Deng, Yiping
Hou, Lisha
Wang, Hui
Yue, Jirong
He, Yong
author_sort Yin, Mengting
collection PubMed
description BACKGROUND: Sarcopenia is an age-related and skeletal muscle disorder involving the loss of muscle mass or strength, and physiological function. Although the diagnostic indicators used in the different guidelines are for muscle mass, strength and physical performance, there are currently no uniform diagnostic criteria. Therefore, we aimed to explore the relationship between a series of biomarkers with sarcopenia in southwest China. METHODS: We included 4302 patients from West China Health and Aging Trend (WCHAT) study. Sarcopenia was defined according to the Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Thyroxine、albumin、total protein、prealbumin、albumin to globulin ratio (A/G)、25(OH)VD、fasting insulin、adrenal cortisol、triglyceride、high-density lipoprotein、hemoglobin and aspartate aminotransferase to alanine aminotransferase ratio (AST/ALT) were measured. The receiver operating characteristic curves (ROC) were established to describe the predictive value for sarcopenia and we also used multivariate logistic regression analysis to identify risk factors of the disease. RESULTS: In terms of protein state, patients with sarcopenia had lower value in total protein, albumin, prealbumin, A/G than the control (P<0.001). Patients had lower value in triglyceride but higher value in high-density lipoprotein compared with the healthy in the indicators of lipid metabolism (P<0.001). In the aspect of hormone state, patients had lower free triiodothyronine, fasting insulin but higher free tetraiodothyronine and adrenal cortisol than the healthy (P<0.001). The fasting insulin level (AUC=0.686) and the AST/ALT ratio (AUC=0.682) were the best predictors of sarcopenia among biomarkers. The diagnostic performance of fasting insulin combined with the AST/ALT ratio (AUC=0.720) is equal to multiple indicators (AUC=0.742). CONCLUSION: The fasting insulin combined with the AST/ALT ratio exhibits good diagnostic performance for sarcopenia.
format Online
Article
Text
id pubmed-8702640
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87026402021-12-25 Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study Yin, Mengting Zhang, He Liu, Qianhui Ding, Fei Deng, Yiping Hou, Lisha Wang, Hui Yue, Jirong He, Yong Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Sarcopenia is an age-related and skeletal muscle disorder involving the loss of muscle mass or strength, and physiological function. Although the diagnostic indicators used in the different guidelines are for muscle mass, strength and physical performance, there are currently no uniform diagnostic criteria. Therefore, we aimed to explore the relationship between a series of biomarkers with sarcopenia in southwest China. METHODS: We included 4302 patients from West China Health and Aging Trend (WCHAT) study. Sarcopenia was defined according to the Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Thyroxine、albumin、total protein、prealbumin、albumin to globulin ratio (A/G)、25(OH)VD、fasting insulin、adrenal cortisol、triglyceride、high-density lipoprotein、hemoglobin and aspartate aminotransferase to alanine aminotransferase ratio (AST/ALT) were measured. The receiver operating characteristic curves (ROC) were established to describe the predictive value for sarcopenia and we also used multivariate logistic regression analysis to identify risk factors of the disease. RESULTS: In terms of protein state, patients with sarcopenia had lower value in total protein, albumin, prealbumin, A/G than the control (P<0.001). Patients had lower value in triglyceride but higher value in high-density lipoprotein compared with the healthy in the indicators of lipid metabolism (P<0.001). In the aspect of hormone state, patients had lower free triiodothyronine, fasting insulin but higher free tetraiodothyronine and adrenal cortisol than the healthy (P<0.001). The fasting insulin level (AUC=0.686) and the AST/ALT ratio (AUC=0.682) were the best predictors of sarcopenia among biomarkers. The diagnostic performance of fasting insulin combined with the AST/ALT ratio (AUC=0.720) is equal to multiple indicators (AUC=0.742). CONCLUSION: The fasting insulin combined with the AST/ALT ratio exhibits good diagnostic performance for sarcopenia. Frontiers Media S.A. 2021-12-10 /pmc/articles/PMC8702640/ /pubmed/34956096 http://dx.doi.org/10.3389/fendo.2021.785045 Text en Copyright © 2021 Yin, Zhang, Liu, Ding, Deng, Hou, Wang, Yue and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Yin, Mengting
Zhang, He
Liu, Qianhui
Ding, Fei
Deng, Yiping
Hou, Lisha
Wang, Hui
Yue, Jirong
He, Yong
Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study
title Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study
title_full Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study
title_fullStr Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study
title_full_unstemmed Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study
title_short Diagnostic Performance of Clinical Laboratory Indicators With Sarcopenia: Results From the West China Health and Aging Trend Study
title_sort diagnostic performance of clinical laboratory indicators with sarcopenia: results from the west china health and aging trend study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702640/
https://www.ncbi.nlm.nih.gov/pubmed/34956096
http://dx.doi.org/10.3389/fendo.2021.785045
work_keys_str_mv AT yinmengting diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT zhanghe diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT liuqianhui diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT dingfei diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT dengyiping diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT houlisha diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT wanghui diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT yuejirong diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy
AT heyong diagnosticperformanceofclinicallaboratoryindicatorswithsarcopeniaresultsfromthewestchinahealthandagingtrendstudy